341. Predictors and long-term impact of sustained complete renal response in lupus nephritis patients over a median 10-year follow-up.
作者: Ioannis E Michelakis.;Eleni Kapsia.;John N Boletis.;Smaragdi Marinaki.;Petros P Sfikakis.;Maria G Tektonidou.
来源: Rheumatology (Oxford). 2026年65卷3期
Complete renal response (CRR) is a primary goal in lupus nephritis (LN) management. We examined the prevalence and predictors of sustained CRR (sCRR) and long-term outcomes.
343. Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohort.
作者: Yuka Morita.;Koichi Takeda.;Hiroki Osumi.;Yosuke Aoyama.;Naoki Fukuda.;Keitaro Shimozaki.;Shohei Udagawa.;Shota Fukuoka.;Mariko Ogura.;Takeru Wakatsuki.;Akira Ooki.;Keisho Chin.;Eiji Shinozaki.;Toshimi Takano.;Taro Shiga.;Kensei Yamaguchi.
来源: Rheumatology (Oxford). 2026年65卷2期
To evaluate the efficacy of glucocorticoid-sparing management in patients with G-CSF-associated large-vessel vasculitis (LVV).
345. International development and validation of a multilingual bank of items for the self-assessment of essential knowledge by systemic lupus erythematosus patients: the SLE Knowledge Assessment score (SLAKE).
作者: Antonin Satrin.;Matteo Piga.;Mariele Gatto.;Yurilis Fuentes-Silva.;José A Gomez Puerta.;Ivan Padjen.;Guillermo Pons-Estel.;Manuel F Ugarte-Gil.;Carlos Enrique Toro-GutiÉrrez.;Alexandra Legge.;Ali Duarte-Garcia.;François Chasset.;Ioannis Parodis.;Katia Baumgaertner.;Laurent Chiche.;Odirlei A Monticielo.;Omondi Oyoo.;Raquel Faria.;Shinji Izuka.;Sofia Silva-Ribeiro.;Galymzhan Togizbayev.;Daniela Opris-Belinski.;Lina El Kibbi.;Amita Aggarwal.;Mithu Maheswaranathan.;Tai-Ju Lee.;Sheilla Achieng.;Anastasiia Shumilova.;Ricard Cervera.;Gamal Chehab.;Faisal Parlindungan.;Sander Van Leuven.;Karoline Lerang.;Jeanette Andersen.;Francesca Marchiori.;Zoe Karakikla-Mitsakou.;Christelle Sordet.;Laurent Arnaud.; .
来源: Rheumatology (Oxford). 2026年65卷2期
Patient education is increasingly acknowledged as an important aspect of the management of systemic lupus erythematosus (SLE). The aim of the study was to develop the SLE Knowledge Assessment score (SLAKE), a digital multilingual self-assessment tool designed to quantify essential SLE knowledge.
346. Early antiproteinuric effect of voclosporin in patients with LN in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience.
作者: Luca Iaccarino.;Aurora Di Gregorio.;Marta Calatroni.;Marco Allinovi.;Alessandra Bortoluzzi.;Giorgio Buscetta.;Rossella De Angelis.;Ginevra De Marchi.;Giacomo Emmi.;Pasquale Esposito.;Paride Fenaroli.;Cinzia Ferio.;Franco Franceschini.;Micaela Fredi.;Francesco Gozza.;Giuliana Marongiu.;Giovanni Orsolini.;Giulia Pazzola.;Daniela Picciotto.;Luca Quartuccio.;Francesca Ruzzon.;Domenico Santoro.;Ettore Silvagni.;Paola Tomietto.;Filippo Vesentini.;Margherita Zen.;Andrea Doria.;Gabriella Moroni.
来源: Rheumatology (Oxford). 2026年65卷1期
To assess efficacy of voclosporin (VCL) from a retrospective, observational, clinical-practice-based, nationwide multicentre study of patients with LN.
347. Immunosuppressant use and adverse pregnancy outcomes in women with systemic lupus erythematosus: a retrospective cohort study in Korea.
作者: Yu-Seon Jung.;Yeo-Jin Song.;Eun Jin Jang.;Soo-Kyung Cho.;Yoon-Kyoung Sung.;Sun-Young Jung.
来源: Rheumatology (Oxford). 2026年65卷2期
This study aimed to estimate the incidence of adverse pregnancy outcomes (APO) in patients with systemic lupus erythematosus (SLE) and to evaluate the risks associated with immunosuppressant use-including hydroxychloroquine and teratogenic agents such as mycophenolate mofetil, methotrexate and cyclophosphamide-across specific APO categories.
348. Comment on: risk of urinary tract infections associated with SGLT2 inhibitor use in patients with rheumatoid arthritis: a target trial emulation study: reply.
作者: Naofumi Dobashi.;Ken-Ei Sada.;Masataka Kudo.;Shigemi Morishita.;Sho Sasaki.;Narufumi Suganuma.
来源: Rheumatology (Oxford). 2026年65卷2期 349. Patient-physician discordance in assessing SLE disease activity: longitudinal analysis of disease-related variables and quality of life.
作者: Agner R Parra Sánchez.;Irene E M Bultink.;Jos W R Twisk.;Ronald F van Vollenhoven.;Alexandre E Voskuyl.;Michel W P Tsang-A-Sjoe.
来源: Rheumatology (Oxford). 2026年65卷2期
To assess the prevalence and factors associated with discordance between patient and physician global assessments (PaGA and PGA) of SLE disease activity over time, and explore residual patient-perceived burden during remission.
350. Current UK practice in pulmonary screening in paediatric connective tissue disease: UK multi-centre audit and proposed standards.
作者: Georgia Southwood.;Katie Mageean.;Mahjouba Ahmid.;Catriona Anderson.;Laura Crosby.;Philip Lawrence.;Catherine Longthorpe.;Sarah Mayell.;Liza McCann.;Francesca Ritchie.;Harriet Sansby.;Elizabeth Twynam-Perkins.;Clare Pain.;Hanna Lythgoe.
来源: Rheumatology (Oxford). 2026年65卷2期
Pulmonary manifestations of CTDs are associated with morbidity and mortality. Early recognition through screening ensures appropriate monitoring and management. The aim of this audit was to define standards for pulmonary screening in CTDs and assess practice in UK tertiary paediatric rheumatology centres.
351. Salience network dysfunction in SLE: convergent roles of complement activation and altered serotonergic signaling.
作者: Xinrui Li.;Linhui Wang.;Qin Huang.;Liwei Tan.;Xia Liu.;Taihan Chen.;Ruiwang Huang.;Xiangliang Tan.
来源: Rheumatology (Oxford). 2026年65卷2期
The neural mechanisms underlying salience network (SN) dysfunction in SLE remain unclear. This study applied a comprehensive multimodal approach to characterize SN abnormalities in SLE patients.
352. Monogenic disorders of the TNF signalling pathway.
TNF is a central regulator of immune responses, inflammation and programmed cell death, and has an essential role in maintaining tissue and immune homeostasis. Abnormal TNF signalling is implicated in a broad spectrum of physiological and pathological processes, as exemplified by monogenic disorders arising from dysregulation of core components of the TNF pathway. These rare conditions encompass various autoinflammatory syndromes, immunodeficiencies, autoimmune diseases and neurodegenerative conditions, and offer unique insights into the molecular mechanisms driving pathology via TNF-mediated inflammation and cell death. Collectively, these diseases underscore the importance of tightly regulated TNF signalling for immune balance and illustrate how distinct molecular defects can produce overlapping clinical phenotypes. Variability in pathway integration and tissue-specific gene expression further shapes disease presentation, whereas disruption of post-translational modifications and cell-death regulators have emerged as central pathogenic mechanisms. Together, these insights highlight the need for precise genetic and mechanistic understanding to inform diagnosis and therapeutic strategies.
353. Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial.
作者: Alice Courties.;Sophie Tuffet.;Grégoire Cormier.;Christian H Roux.;Paul Ornetti.;Yves-Marie Pers.;Jacques-Éric Gottenberg.;Eric Lespessailles.;Roland Chapurlat.;Denis Arniaud.;François Rannou.;Daniel Wendling.;Florent Eymard.;Sylvain Mathieu.;Pascal Richette.;Alain Saraux.;Hubert Marotte.;Nicolas Poursac.;Anne-Christine Rat.;Jean-Philippe Bastard.;Soraya Fellahi.;Yves Henrotin.;Lise Minssen.;Camille Deprouw.;Christelle Nguyen.;Amel Touati.;Laurence Bérard.;Alexandra Rousseau.;Tabassome Simon.;Emmanuel Maheu.;Francis Berenbaum.;Jérémie Sellam.
来源: Lancet Rheumatol. 2026年8卷2期e98-e107页
Erosive hand osteoarthritis is a painful and inflammatory disease without effective treatments. In this study we aimed to investigate the efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) compared with sham stimulation in patients with inflammatory erosive hand osteoarthritis.
357. Development of a PsA-like presentation under anti-IL-13 therapy with tralokinumab for atopic dermatitis.
作者: Katya Meridor.;Sook Yan Lee.;Ilona Blee.;Jane E Freeston.;Philip M Laws.;Gabriele De Marco.;Kerem Abacar.;Tom Macleod.;Emma Rowbotham.;Timothy Palmer.;Andrea Di Matteo.;Richard Woolf.;Catherine Smith.;Andrew Pink.;Helena Marzo-Ortega.;Bruce Kirkham.;Dennis McGonagle.
来源: Rheumatology (Oxford). 2026年65卷3期
Dual blockade of IL-4 and IL-13 in atopic dermatitis (AD) has been associated with activation of the IL-23/IL-17 axis, potentially leading to paradoxical psoriasis and PsA-like presentation. However, the specific cytokine responsible for these reactions remains unclear. We report a case series of PsA-like presentation following treatment with tralokinumab, an anti-IL-13 monoclonal antibody used for AD.
358. Redox imbalance and NLRP3 activation: H syndrome mistaken for CAPS-a case report.
作者: Serena Palmeri.;Anna Agrusti.;Valentina Natoli.;Silvia Maria Orsi.;Enrico Drago.;Federica Penco.;Francesca Schena.;Paola Bocca.;Ignazia Prigione.;Roberta Bertelli.;Silvia Viaggi.;Riccardo Papa.;Stefano Volpi.;Roberta Caorsi.;Marco Gattorno.
来源: Rheumatology (Oxford). 2026年65卷2期
H syndrome is a rare autosomal recessive disorder caused by mutations in SLC29A3, encoding the nucleoside transporter hENT3. Its heterogeneous clinical presentation often includes skin hyperpigmentation, systemic inflammation, endocrinopathies and sensorineural hearing loss. However, typical cutaneous signs may be absent, leading to diagnostic challenges. The objective was to describe a patient with H syndrome misdiagnosed until adulthood as having cryopyrin-associated periodic syndrome (CAPS), due to overlapping clinical and functional features.
359. The influence of baseline aortitis on aortic dilation risk in GCA: a multicentre imaging study.
作者: Chiara Marvisi.;Konstanze V Guggenberger.;Giulia Besutti.;Rudolf A Werner.;Pamela Mancuso.;Sebastian E Serfling.;Roberto Farì.;Michael Gernert.;Rexhep Durmo.;Matthias Fröhlich.;Caterina Ricordi.;Hannah Labinsky.;Luigi Boiardi.;Jost Hillenkamp.;Lucia Spaggiari.;Annibale Versari.;Pierpaolo Pattacini.;Paolo Giorgi Rossi.;Thorsten A Bley.;Carlo Salvarani.;Marc Schmalzing.;Francesco Muratore.
来源: Rheumatology (Oxford). 2026年65卷3期
To assess the prevalence of aortitis and aortic dilation at diagnosis, estimate the progression of aortic diameter over time, and identify predictors of incident aortic dilation development in patients with newly diagnosed GCA.
360. The contribution of salivary gland ultrasound to juvenile Sjögren disease classification: performance of a weighted scoring model.
This study evaluated the classification utility of incorporating parotid gland US for juvenile Sjögren's disease (jSjD) by testing its role in a weighted scoring (WS) model and comparing it with the standard 2016 ACR/EULAR classic model (CM).
|